Related Experiment Videos
Antibodies against Candida: potential therapeutics?
1University Dept of Medical Microbiology, Manchester Royal Infirmary, UK.
Trends in Microbiology
|September 1, 1996
Summary
Specific antibodies targeting mannoproteins and hsp90 demonstrate protective immunity against Candida infections in mice. Advances in antibody engineering suggest potential for developing new antibody-based therapeutics for candidiasis.
Area of Science:
- Immunology
- Microbiology
- Therapeutics Development
Background:
- The role of antibodies in immunity to Candida infections has been debated for years.
- Recent studies indicate protective effects of specific antibodies against Candida.
- Mannoproteins and heat shock protein 90 (hsp90) are identified as key targets.
Purpose of the Study:
- To investigate the protective role of specific antibodies against Candida infections.
- To explore the potential of antibody engineering for therapeutic applications in candidiasis.
Main Methods:
- Murine model of candidiasis.
- Assessment of antibody-mediated protection.
- Leveraging advances in antibody engineering.
Main Results:
- Specific antibodies targeting mannoproteins were found to be protective.
- Antibodies against hsp90 also demonstrated protective effects in murine candidiasis.
- Technical progress in antibody engineering facilitates therapeutic development.
Conclusions:
- Antibodies against mannoproteins and hsp90 are crucial for protective immunity against Candida.
- Engineered antibodies hold promise as novel therapeutics for treating candidiasis.